Roundtable#1 : Why change DAPT practice?
- What are the regional experts’ views on controversies surrounding DAPT guidelines and how do they address them?
- How do I define HBR in real life?
- Should I change DAPT practice for complex PCI patients?
- How do I manage a true high thrombotic and high bleeding risk PCI patient?
Roundtable#2 : How to change DAPT practice?
- What value do clinical trials relating to DAPT duration bring and how can I utilize the results?
- What are the techniques to reduce overall bleeding complications?
- How do I choose the best drug for DAPT?
- What measures should I take to ensure the safety of complex PCI patients if I place them on short DAPT?
MASTER DAPT study is sponsored by the European Cardiovascular Research Institute (ECRI, Rotterdam, The Netherlands) and supported with a restricted research grant by Terumo Europe.